Peter Dukor

Title: The Innovative Contributions of Peter Dukor

Introduction

Peter Dukor is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmacology, particularly through his innovative work on immunomodulating agents. His research has implications for vaccine development and allergy treatment.

Latest Patents

Dukor holds a patent for Muramyl dipeptide derivatives, specifically the 3-O-[N-acetylmuramyl-D-isoglutaminyl]-1,2-di-O-palmitoyl-sn-glycerol derivative. This compound possesses interesting pharmacological properties, particularly in immunomodulation. It is particularly useful as an immunomodulant, as an adjuvant in vaccines, and as a suppressing agent for IgE formation in type I allergies and atopic dermatitis. The compound is obtained by deprotection of a corresponding compound that has one or more hydroxy groups in protected form. He has 1 patent to his name.

Career Highlights

Dukor's career has been marked by his dedication to research and development in the pharmaceutical industry. He works at Sandoz GmbH, where he continues to explore innovative solutions to complex health issues. His work has garnered attention for its potential to improve patient outcomes through advanced therapeutic options.

Collaborations

Throughout his career, Dukor has collaborated with esteemed colleagues, including Louis A. Chedid and Pierre Lefrancier. These partnerships have enriched his research and contributed to the advancement of their shared goals in the field of immunology.

Conclusion

Peter Dukor's contributions to immunology and pharmacology highlight the importance of innovation in addressing health challenges. His work continues to inspire advancements in vaccine development and allergy treatment.